+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DelveInsight - Market Research Reports

Delve Insight authors market leading reports across the pharmaceutical and biotechnology sectors. The key findings and insights all come from regular monitoring of developments through the pharmaceutical and biotechnology sectors. These findings are then published through market forecasts, drug pipelines and drug insights, along with advice from top market analysts on how to best use this, alongside the detailed market forecasts offered by Delve Insight.

High-Grade Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

High-Grade Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 200 Pages
  • Global
From
Corneal Endothelial Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Corneal Endothelial Dystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Mesothelioma - Pipeline Insight, 2025 - Product Thumbnail Image

Mesothelioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Malignant Pleural Mesothelioma- Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Pleural Mesothelioma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Meningioma - Pipeline Insight, 2025 - Product Thumbnail Image

Meningioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
H3N2 Infection - Pipeline Insight, 2025 - Product Thumbnail Image

H3N2 Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Interleukin-18 (IL-18) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-18 (IL-18) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Proteasome Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proteasome Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Essential Thrombocythemia - Pipeline Insight, 2025 - Product Thumbnail Image

Essential Thrombocythemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Malignant Mesothelioma - Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Mesothelioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 110 Pages
  • Global
From
Malt Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Malt Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Abnormal Glucose Tolerance- - Pipeline Insight, 2025 - Product Thumbnail Image

Abnormal Glucose Tolerance- - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Opioid Withdrawal Syndrome- - Pipeline Insight, 2025 - Product Thumbnail Image

Opioid Withdrawal Syndrome- - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Polypoidal Choroidal Vasculopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Polypoidal Choroidal Vasculopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pericarditis - Pipeline Insight, 2025 - Product Thumbnail Image

Pericarditis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Pediatric Growth Hormone Deficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Pediatric Growth Hormone Deficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Refractory Metastatic Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Refractory Metastatic Melanoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator